March 31, 2025 - 04:42

Mount Nittany Health has initiated a federal lawsuit claiming that the Blue Cross Blue Shield Association and its affiliated insurers have participated in collusion that negatively impacts healthcare providers and patients alike. The lawsuit asserts that these practices have created an unfair environment, limiting competition and harming the quality of care available to patients.
According to the allegations, the insurance giant's actions have led to reduced reimbursement rates for healthcare services, ultimately affecting the financial stability of healthcare providers. This situation, as described in the lawsuit, has forced many facilities to operate under unsustainable conditions, compromising their ability to deliver quality care.
Mount Nittany Health argues that the collusion has resulted in a detrimental cycle that not only affects healthcare providers but also places a burden on patients seeking necessary medical treatments. The lawsuit seeks to hold the Blue Cross Blue Shield Association accountable for its alleged role in fostering an anti-competitive atmosphere within the healthcare sector. As this legal battle unfolds, it could have significant implications for the broader healthcare landscape.
July 23, 2026 - 15:06
Good riddance to bundled ‘global’ maternal care billingThe American College of Obstetricians and Gynecologists is welcoming a major shift in how pregnancy and childbirth are billed. For years, the system relied on a single, bundled `global` fee that...
July 22, 2026 - 21:50
West Nile virus found in two mosquito traps in DeKalb County, health officials sayHealth authorities in DeKalb County have confirmed that mosquitoes collected from two separate traps have tested positive for the West Nile virus. The positive samples were identified during...
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...